Tissue Repair
Tissue Repair Research Peptides
Grouping these compounds by outcome hides how differently they are proposed to work. BPC-157 is a synthetic 15-residue fragment of a gastric protein, studied largely around nitric-oxide signalling. TB-500 is a synthetic fragment of thymosin beta-4, studied around actin binding and cell migration. GHK-Cu is a copper-binding tripeptide whose literature sits in matrix remodelling and has almost nothing in common with the other two. KPV is a three-residue fragment of alpha-MSH.
So "tissue repair" is a shelf, not a mechanism, and each product page treats its compound's literature on its own terms.
Those literatures also differ in quality, and the pages say so. A large share of the published BPC-157 work traces to one research group and remains preclinical — a limitation the recent reviews state plainly. Each product page reports how many primary papers it cites, over what period, and whether they concentrate in a single group, so the evidence base can be weighed rather than assumed.
Every batch is independently assayed before release, with purity and measured content both published and tied to the lot code on the vial. Supplied strictly for in-vitro laboratory research, shipped domestically within the United States.
In this category: BPC-157 · TB-500 · KPV · GHK-Cu · IGF-1 LR3
What to check before buying tissue repair compounds
Purity is half the number. A purity figure tells you what fraction of the powder in the vial is the compound on the label — it tells you nothing about how much powder is in the vial. A lot can assay at 99.8% purity and still be short against its labelled content.
Both numbers are published for every batch here: purity from HPLC, and measured mass against expected content. Match the batch code printed on the vial to the certificate before you rely on either.
Tissue Repair research peptides — common questions
- What is BPC-157, structurally?
- A synthetic 15-amino-acid sequence derived from a protein found in gastric juice. It has no approved medicine equivalent, which means its entire evidence base is preclinical. A large share of that literature also originates from one research group, a concentration the published reviews state plainly and one worth weighing before reading volume as consensus.
- Is TB-500 the same thing as thymosin beta-4?
- No. Thymosin beta-4 is the complete 43-residue peptide; TB-500 is a synthetic fragment of it, typically the actin-binding region. Research conducted on the full peptide is not automatically research on the fragment, and the two are cited separately on the product pages for that reason.
- What makes GHK-Cu different from the other repair compounds?
- It carries a copper ion. GHK-Cu is a copper-binding tripeptide, and its literature centres on collagen and extracellular matrix remodelling rather than on the nitric-oxide and angiogenesis pathways proposed for BPC-157. The blue-green colour of the solution comes from the copper and is expected rather than a defect.
- How do I check a vial against its certificate?
- Read the lot code off the vial label and look it up. Every certificate this store publishes is issued against a lot code rather than against a product name, so one that carries no lot code says nothing about a particular unit. The batch lookup resolves a code directly to its report.
